Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.
Semaglutide 對於肥胖相關心臟衰竭患者心臟結構和功能的影響。
J Am Coll Cardiol 2024-09-01
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Semaglutide對心臟收縮功能保留型心衰患者的症狀、功能和生活品質的影響:STEP-HFpEF試驗的預先指定分析。
Circulation 2024-04-03
Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
Semaglutide在輕度降低或保留射血分數心衰患者中的肥胖症。
J Am Coll Cardiol 2024-04-30
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Semaglutide與安慰劑在肥胖相關心臟衰竭患者中的比較:STEP-HFpEF和STEP-HFpEF DM隨機試驗的綜合分析。
Lancet 2024-04-10
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Semaglutide與利尿劑在與肥胖相關的保留射血分數心臟衰竭中的應用:STEP-HFpEF和STEP-HFpEF-DM試驗的綜合分析。
Eur Heart J 2024-05-13
Efficacy and safety of semaglutide in patients with heart failure with preserved ejection fraction and obesity.
Semaglutide在心臟收縮功能保留但合併肥胖症患者中的療效和安全性。
Clin Cardiol 2024-05-22
Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program.
Semaglutide在肥胖相關心臟衰竭伴隨保留射血分數的NYHA功能分級:STEP-HFpEF計畫。
J Am Coll Cardiol 2024-06-24
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
心衰竭患者中 Semaglutide 與安慰劑的比較:SELECT、FLOW、STEP-HFpEF 和 STEP-HFpEF DM 隨機試驗的綜合分析。
Lancet 2024-09-02